Hu antigen-derived peptides and uses thereof
CA 2387391 A1 · Owner: Gherardi, Romain K. · Inventors: Farcet, Jean-Pierre; Garcia-Pons, Francisco; Bourguin-Plonquet, Anne
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to Hu antigen-derived peptides and to their use and more particularly to their use in the diagnostic in the prevention and in , the, treatment of certain types of cancer and neuronal damage. The immunogenic peptides of the invention are capable of generating cytotoxic CD8 Tlymphocytes, (CTLs) which may eliminate undesirable cells such as SCLC cancerous cell without reacting against non-cancerous such as neural cells. The invention also, provides nucleotides coding these immunogenic peptides and antibodies binding thereto.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 8, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 8, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 8, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.